AstraZeneca PLC/ GB0009895292 /
2024-03-06 2:15:54 PM | Chg. - | Volume | Bid9:00:03 AM | Ask9:00:03 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,332.50SEK | - | 160 Turnover: 213,200 |
-Bid Size: - | -Ask Size: - | 2218.76 bill.SEK | - | - |
GlobeNewswire
11:00 AM
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
GlobeNewswire
1:00 AM
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
03-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...